Barclays raised the firm’s price target on Celestica (CLS) to $157 from $139 and keeps an Overweight rating on the shares after meeting with ...
CLS is well poised for sustained growth backed by robust infrastructure investments, solid technology know-how and wide industry experience.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback